A host of companies are competing to bring cancer-detecting blood tests to market.

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.

Tumour marker tests detect substances linked to cancer but cannot diagnose cancer alone and must be interpreted with other ...

A new study suggests the investigational Stockholm3 blood test may improve the early detection of aggressive prostate cancer ...

Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over 12,000 men in Sweden.

Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...

A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence, Swedish ...

New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors ...

A private company advising the agency that oversees Medicare has recommended against reimbursing for the biomarker tests, ...

Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...

Northwestern Medicine scientists have demonstrated that a highly sensitive blood test can detect traces of pancreatic cancer ...

New research has uncovered persistent disparities in preventive cancer care across different sexual orientation and gender ...